New Delhi, Dec 26 (IANS) Union Health Minister JP Nadda on Friday undertook a review of the progress of Indian Pharmacopoeia Commission to ensure the quality of medicines.
Gandhinagar, Dec 26 (IANS) The Gujarat Industrial Development Corporation (GIDC) is set to establish a new, sector-specific Medical Device Park at Nagalpar in Rajkot. This initiative aims to create a comprehensive ecosystem for the medical device industry, supporting manufacturing, research, and global export.
New Delhi, Dec 26 (IANS) From changing the definition to the rise of GLP-1 medications, and the government’s several initiatives, especially Prime Minister Narendra Modi's clarion call, obesity became the focus of healthcare in India in 2025.
New Delhi, Dec 26 (IANS) Women working on the night shift or frequently flying across time zones, where they experience an irregular sleep schedule, may increase their risk of aggressive breast cancer, according to a study.
New Delhi, Dec 26 (IANS) 2025 has been a year of evidence-based growth, global leadership, and people-centric healthcare for the Ayush sector.
New Delhi, Dec 26 (IANS) A newly developed artificial intelligence (AI) model is highly accurate in predicting blood loss in patients undergoing high-volume cosmetic surgery procedures, such as liposuction, according to a study.
Gandhinagar, Dec 25 (IANS) The Gujarat government's Foster Parent Scheme (Palak Mata-Pita Yojana) has emerged as a lifeline for orphaned and abandoned children in Banaskantha district, ensuring that no child grows up without care, protection or a family environment.
New Delhi, Dec 25 (IANS) India’s food safety regulator has tightened the rules on what can be officially called “tea”, making it clear that only products made from the plant Camellia sinensis can use the word on their labels.
New Delhi, Dec 25 (IANS)With GST reforms and Research Development Incentive (RDI) Scheme, the year 2025 has been a crucial turning point for Indian pharma, said industry experts on Thursday, while highlighting innovation and increased access as key factors for the sector’s growth in 2026.
New Delhi, Dec 25 (IANS) Sun Pharma’s US arm, Taro Pharmaceutical Industries, has recalled more than 17,000 units of antifungal over manufacturing issues, the US Food and Drug Administration (USFDA) has said.
